Clin2
NCT07415655Possibly a fitRecruiting

Albumin for stroke in the front of the brain

Ischemic Stroke

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether giving albumin (a protein naturally in your blood) can help protect your brain after an ischemic stroke in the front part of your brain. You need to be planning a procedure to open the blocked vessel.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had an ischemic stroke (a clot) in the front part of your brain
  • You are scheduled for a procedure to open a blocked blood vessel (like a thrombectomy)
  • You are not pregnant or breastfeeding
  • You have no known allergy to albumin
  • You do not have conditions like too much fluid in your body, overhydration, or high sodium levels

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06383182Recruiting
Study of blood markers after stroke artery treatment

This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.

Shenyang
NCT04664946Recruiting
Intra-arterial treatment for stroke when no reperfusion was given

This trial tests an “intra-arterial” approach (a treatment delivered through an artery to the brain) for people with ischemic stroke who were not given clot-busting therapy or a clot-removal procedure. It aims to improve neurological recovery when there wasn’t reperfusion therapy, including in cases where symptoms worsen soon after stroke.

Shenyang
NCT07127484Recruiting
Blood filtering for severe stroke

This trial tests whether filtering inflammatory substances from the blood using a special device can improve recovery in people with severe ischemic stroke. You must be within 48 hours of stroke onset and have significant disability or large areas of brain injury.

Wuhu, Anhui
NCT06571149Recruiting· Phase 4
Blood thinners and clot-busting drugs for stroke

This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.

Eisenstadt
NCT07263308Recruiting· Phase 3
Albumin for large artery stroke after clot removal

This trial tests whether giving albumin, a protein naturally found in blood, can improve recovery after a large artery stroke when given along with a procedure to remove the clot. It's for people aged 18-80 who have a stroke from a blockage in the front part of the brain and can get treatment within 24 hours.

Fuyang, Anhui
NCT07365475Not yet recruiting· Phase 2
Albumin treatment after stroke clot removal

This trial tests whether adding albumin (a protein) to standard clot removal can improve recovery for people with a large vessel blockage stroke. You may qualify if you just had successful clot removal and meet health criteria.

Hear when a new Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.